Update: Iovance Biotherapeutics Shares Jump After 2026 Revenue Guidance Raised
MT newswire2026/09/29 19:05Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
03:05 PM EDT, 09/29/2026 (MT Newswires) -- (Updates with stock movement in headline and first paragraph.) Iovance Biotherapeutics (IOVA) shares jumped 35% in Tuesday trading after the company raised its 2026 revenue guidance to $410 million to $420 million from its prior outlook of $350 million to $370 million. Analysts polled by FactSet expect $402.8 million. Iovance cited strong US demand for Amtagvi and Proleukin. Price: 14.89, Change: +3.90, Percent Change: +35.48
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Japanese stocks closed down 0.05%, marking five consecutive losses.
格隆汇•2026/10/14 06:41
Morgan Stanley raises Unity's target price to $55
格隆汇•2026/10/14 06:17
Timmer: Investment Clock Hits ‘Past Midnight’ Zone Seen Before 2018, 2022 Slumps
BeInCrypto•2026/10/14 05:51
Fed’s Williams sees AI supply squeeze lasting beyond 2 years
Cointelegraph•2026/10/14 05:33
Crypto prices
More
Bitcoin
BTC
$83,341.36
-0.41%
Ethereum
ETH
$2,502.7
-1.20%
Tether USDt
USDT
$0.9989
+0.02%
BNB
BNB
$741.89
-0.39%
XRP
XRP
$1.37
-0.74%
USDC
USDC
$0.9998
-0.00%
Solana
SOL
$107.08
-1.36%
TRON
TRX
$0.3311
+0.36%
Zcash
ZEC
$1,251.52
+2.81%
Hyperliquid
HYPE
$81.85
-1.56%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now